- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03815045
Ultrasound Guided Diagnostic Lumbar Puncture in Neurology
January 29, 2024 updated by: Dartmouth-Hitchcock Medical Center
Subjects who are having a lumbar puncture as part of their clinical care will be randomized to either a traditional landmark based lumbar puncture or ultrasound guided lumbar puncture.
The primary objective of study is to compare the success rate of obtaining CSF using Ultrasound guided technique against the Traditional Landmark based approach.
Secondary objectives are to evaluate factors influencing the success or failure, patient tolerance, and a safety assessment.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Seventy-two subjects will be randomized into either a traditional landmark-based lumbar puncture or an ultrasound-guided lumbar puncture for obtaining CSF.
This study will be conducted in the Neurology clinic.
For subjects in the traditional group, the site of needle entry will be determined through palpation of the spine.
For subjects in the ultrasound group, site entry will be done using ultrasound guidance.
Success and failure of these techniques will be compared along with secondary outcome measures aimed at assessing the safety and efficacy of each of these techniques.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient scheduled for LP through Neurology's LP clinic
- 18 years of age or older
- Able to understand the description of procedure and provide informed consent
Exclusion Criteria:
- Any contraindications to doing a standard lumbar puncture; which typically includes risk of bleeding from effects of anticoagulants or bleeding disorders or an infection at the potential site of entry in the back. This includes subjects with spinal cord stimulators.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Landmark-based lumbar puncture
Landmark-based LP
|
Traditional landmark based lumbar puncture involves palpating spinous processes on the back and finding the inter-spinous space which is the site of needle entry to gain access to the thecal sac.
Finding this space may be difficult by palpation, especially when subjects undergoing the procedure are obese, elderly, have had prior back surgery, or if the patient is positioned incorrectly.
|
|
Active Comparator: Ultrasound-guided lumbar puncture
Ultrasound-guided LP
|
Ultrasound guided lumbar puncture is a novel technique being increasingly utilized by emergency physicians, pediatricians and anesthesiologists.
In this technique, an ultrasound probe is used to visualize the inter-spinous space.
This space can be marked on the skin as the potential point of entry.
This could potentially make it easier when patient factors make it difficult to palpate and find the site of entry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate of obtaining CSF within 3 attempts
Time Frame: During the baseline visit, approximately 1 hour
|
The success of the procedure is defined as the ability to obtain CSF within 3 attempts via Landmark based LP vs Ultrasound guided LP
|
During the baseline visit, approximately 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to completion of LP, in minutes
Time Frame: Immediately following consent, during baseline visit, approximately 1 hour
|
Time taken to complete procedure, either traditional vs. ultrasound LP, to obtain CSF
|
Immediately following consent, during baseline visit, approximately 1 hour
|
|
Number of attempts to obtain CSF
Time Frame: Immediately following consent, during baseline visit
|
The number of attempts it takes to obtain CSF
|
Immediately following consent, during baseline visit
|
|
Incidence of traumatic tap
Time Frame: Time taken to run analysis of CSF RBC count, approximately within 1 day
|
defined as CSF RBC count >400/ml
|
Time taken to run analysis of CSF RBC count, approximately within 1 day
|
|
Pain after the procedure
Time Frame: Immediately post-procedure, approximately 5 minutes
|
Universal Pain Assessment Tool: Subject-reported pain level as rated on a scale of 0 - 10. Lower score indicates a better outcome.
|
Immediately post-procedure, approximately 5 minutes
|
|
Occurrence of post LP headache
Time Frame: Phone call within 72 hours of procedure
|
Subject-reported incidence of post LP headache within 72 hours
|
Phone call within 72 hours of procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2017
Primary Completion (Actual)
March 10, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
January 22, 2019
First Submitted That Met QC Criteria
January 23, 2019
First Posted (Actual)
January 24, 2019
Study Record Updates
Last Update Posted (Estimated)
January 31, 2024
Last Update Submitted That Met QC Criteria
January 29, 2024
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D17180
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Puncture
-
Thomas Jefferson UniversityMayo ClinicCompleted
-
Boston Children's HospitalCompletedTraumatic Lumbar PunctureUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Injeq LtdCompleted
-
Seattle Children's HospitalLife Sciences Development FundUnknown
-
University of Alabama at BirminghamCompletedPediatric Lumbar PunctureUnited States
-
Columbia UniversityCompletedInfant Lumbar PunctureUnited States
-
Children's Hospital of PhiladelphiaActive, not recruiting
-
Injeq LtdCompletedPediatric Lumbar PunctureFinland
-
University of NebraskaUnknownIndication for Lumbar PunctureUnited States
Clinical Trials on Landmark-based lumbar puncture
-
Mayo ClinicTerminated
-
Kenichiro YamagataCompletedAtrial Fibrillation | Peripheral Vascular Disease | Vascular Access ComplicationsCzechia, Japan
-
University of NebraskaUnknownIndication for Lumbar PunctureUnited States
-
Guy's and St Thomas' NHS Foundation TrustNot yet recruitingIdiopathic Intracranial Hypertension | Eye Change
-
IRCCS San RaffaeleTeresa Calimeri; Sara SteffanoniRecruiting
-
Universitair Ziekenhuis BrusselRecruitingAlzheimer Disease | Mild Cognitive ImpairmentBelgium
-
The Netherlands Cancer InstituteCompletedMeningeal CarcinomatosisNetherlands
-
University Hospital, ToursCompleted
-
Azienda Usl di BolognaCompleted
-
QualissimaEuropean UnionCompletedMILD COGNITIVE IMPAIRMENTFrance, Germany, Greece, Italy, Netherlands, Spain